InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,304.72
(
0.70%
)
US TECH 100
18,318.00
(
0.95%
)
Dow Jones
39,069.59
(
0.01%
)
Brent Oil
81.95
(
-0.02%
)
Bitcoin
68,679.48
(
-0.85%
)
Post# of 459921
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Talon38

Send PM Follow Ignore
Followers 29
Posts 2179
Boards Moderated 0
Alias Born 12/13/2016

Talon38

Re: Talon38 post# 105450

Wednesday, 05/17/2017 10:41:32 PM

Wednesday, May 17, 2017 10:41:32 PM

Post# of 459921
Besides Aricept, Eisai has two other drugs for Alzheimer's in joint development with Biogen. E2609 is a BACE inhibitor(JP/US/EU P2) and BAN2401 a monoclonal antibody(JP/US/EU P1). Both of these drugs like Bioigen's Aducanumab are directed towards reducing amyloid plaques which leads them down a road littered with failed drug candidates. If both of these drug companies determine the 2-73/3-71 Sigma I platform is superior to their drugs or even worth a closer clinical evaluation, they have the capability and the trial apparatus to conduct JP/US/EU trials. Take a look at Eisai's website and see the very extensive line up of drugs they have under development.

A part of the puzzle?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News
InvestorsHub NewsWire

Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM

Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM

"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM

North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM

Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM

Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM

Start posting your company's news
Only $200 per official company press release!